Canada Life’s Accelerate Diagnostics AXDX Stock Holding History

Canada Life’s Portfolio AXDX Stock Details AXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-198	Closed	-$3K	–	2432
2022 Q1	$3K	Hold	198	–	–	﹤0.01%	2473
2021 Q4	$10K	Hold	198	–	–	﹤0.01%	2446
2021 Q3	$12K	Hold	198	–	–	﹤0.01%	2495
2021 Q2	$16K	Hold	198	–	–	﹤0.01%	2513
2021 Q1	$16K	Hold	198	–	–	﹤0.01%	2531
2020 Q4	$15K	Hold	198	–	–	﹤0.01%	2567
2020 Q3	$21K	Hold	198	–	–	﹤0.01%	2427
2020 Q2	$30K	Hold	198	–	–	﹤0.01%	2394
2020 Q1	$17K	Hold	198	–	–	﹤0.01%	2400
2019 Q4	$33K	Buy	+198	New	+$32.7K	﹤0.01%	2394
2019 Q3	–	Sell	-255	Closed	-$58K	–	1223
2019 Q2	$58K	Sell	255 -385	-60%	-$75.3K	﹤0.01%	2404
2019 Q1	$134K	Buy	640 +432	+208%	+$81K	﹤0.01%	1974
2018 Q4	$23K	Hold	208	–	–	﹤0.01%	2523
2018 Q3	$48K	Hold	208	–	–	﹤0.01%	2405
2018 Q2	$46K	Hold	208	–	–	﹤0.01%	2418
2018 Q1	$48K	Hold	208	–	–	﹤0.01%	2378
2017 Q4	$54K	Hold	208	–	–	﹤0.01%	2340
2017 Q3	$46K	Hold	208	–	–	﹤0.01%	2351
2017 Q2	$57K	Hold	208	–	–	﹤0.01%	2282
2017 Q1	$50K	Hold	208	–	–	﹤0.01%	2303
2016 Q4	$43K	Hold	208	–	–	﹤0.01%	2358
2016 Q3	$57K	Hold	208	–	–	﹤0.01%	2300
2016 Q2	$30K	Hold	208	–	–	﹤0.01%	2422
2016 Q1	$30K	Hold	208	–	–	﹤0.01%	2280
2015 Q4	$45K	Hold	208	–	–	﹤0.01%	2184
2015 Q3	$34K	Hold	208	–	–	﹤0.01%	2217
2015 Q2	$54K	Buy	+208	New	+$49.7K	﹤0.01%	2172

Other funds holding AXDX

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

CIA

Cladis Investment Advisory Billings, Montana $214M AUM 45.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BAM

Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return

Canada Life's AXDX Position: Q2 2022 in Review

Canada Life sold out of Accelerate Diagnostics (AXDX) in Q2 2022, closing a stake of 198 shares — an estimated $3K sold.

Canada Life first reported a position in AXDX in Q2 2015 and held it in 27 quarters. The position peaked at $134K in Q1 2019. 74 funds tracked by Wall St. Rank hold AXDX as of Q2 2022.

Canada Life reported no remaining Accelerate Diagnostics position as of Q2 2022 after selling out during the quarter.
Canada Life sold 198 Accelerate Diagnostics shares in Q2 2022, an estimated $3K.
Canada Life first reported a position in Accelerate Diagnostics in Q2 2015 and held it in 27 quarters.
Canada Life's Accelerate Diagnostics position peaked at $134K in Q1 2019.
74 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2022.

Based on Canada Life's 13F filing for Q2 2022, filed 9 Aug 2022.